Synthetic trimeric interleukin-6 receptor complexes with a STAT3 phosphorylation dominated activation profile

IF 3.7 3区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Christiane Seibel , Silke Pudewell , Puyan Rafii , Julia Ettich , Hendrik T. Weitz , Alexander Lang , Patrick Petzsch , Karl Köhrer , Doreen M. Floss , Jürgen Scheller
{"title":"Synthetic trimeric interleukin-6 receptor complexes with a STAT3 phosphorylation dominated activation profile","authors":"Christiane Seibel ,&nbsp;Silke Pudewell ,&nbsp;Puyan Rafii ,&nbsp;Julia Ettich ,&nbsp;Hendrik T. Weitz ,&nbsp;Alexander Lang ,&nbsp;Patrick Petzsch ,&nbsp;Karl Köhrer ,&nbsp;Doreen M. Floss ,&nbsp;Jürgen Scheller","doi":"10.1016/j.cyto.2024.156766","DOIUrl":null,"url":null,"abstract":"<div><div>In Interleukin (IL)-6 signalling, IL-6 site I binds to the IL-6 receptor (IL-6R) first, following by IL-6 site II interaction to domain 2/3 of gp130 to form premature trimeric IL-6:IL–6R:gp130 receptor complexes. Formation of the mature hexameric receptor complex is then facilitated by the inter-trimeric interaction of IL-6 site III with domain 1 of the opposing gp130. The two gp130-associated Janus kinases (JAKs) <em>trans</em>-phosphorylate when their spatiotemporal pairing is correct, which causes the activation of STAT, ERK, and AKT pathways in a balanced manner. Since the intracellular domain (ICD) of IL-6R is not needed for STAT/ERK/AKT phosphorylation, we investigated the conditions under which a chimeric IL-6R<sub>ECD</sub>-gp130<sub>TMD/ICD</sub> receptor protein confers biological activity. For IL–6R<sub>ECD</sub>–gp130<sub>TMD/ICD</sub>, the extracellular domain (ECD) of IL-6R was fused to the transmembrane domain (TMD) and ICD of gp130. Co-expression of IL–6R<sub>ECD</sub>–gp130<sub>TMD/ICD</sub> with signalling-deficient gp130 variants did not induce IL-6 signalling, suggesting that the assembly of hexameric complexes failed to dimerize the IL-6R-associated JAKs correctly. By mimicking the premature trimeric receptor complex, IL-6-mediated dimerization of IL-6R<sub>ECD</sub>-gp130<sub>TMD/ICD</sub> with the single-cytokine-binding variant gp130<sub>ΔD1</sub> induced signalling. Of note, IL-6 signalling via these synthetic gp130<sub>ΔD1</sub>:IL-6R<sub>ECD</sub>-gp130<sub>TMD/ICD</sub> complexes resulted predominantly in STAT3 phosphorylation. A STAT3-dominated profile was also observed after IL-6-induced signalling mediated by a JAK-deficient IL–6R<sub>ECD</sub>–gp130<sub>TMD/ICDΔJAK</sub> variant in complex with the JAK-proficient but STAT/ERK/AKT-deficient gp130<sub>JAKΔICD</sub> variant. Our data showed that effective ERK/AKT signalling could not be executed after intracellular domain swapping from gp130 to the IL-6R. Taken together, the chimeric IL-6R/gp130 receptor may be helpful in the creation of customized synthetic IL-6 signalling.</div></div>","PeriodicalId":297,"journal":{"name":"Cytokine","volume":"184 ","pages":"Article 156766"},"PeriodicalIF":3.7000,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytokine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043466624002709","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In Interleukin (IL)-6 signalling, IL-6 site I binds to the IL-6 receptor (IL-6R) first, following by IL-6 site II interaction to domain 2/3 of gp130 to form premature trimeric IL-6:IL–6R:gp130 receptor complexes. Formation of the mature hexameric receptor complex is then facilitated by the inter-trimeric interaction of IL-6 site III with domain 1 of the opposing gp130. The two gp130-associated Janus kinases (JAKs) trans-phosphorylate when their spatiotemporal pairing is correct, which causes the activation of STAT, ERK, and AKT pathways in a balanced manner. Since the intracellular domain (ICD) of IL-6R is not needed for STAT/ERK/AKT phosphorylation, we investigated the conditions under which a chimeric IL-6RECD-gp130TMD/ICD receptor protein confers biological activity. For IL–6RECD–gp130TMD/ICD, the extracellular domain (ECD) of IL-6R was fused to the transmembrane domain (TMD) and ICD of gp130. Co-expression of IL–6RECD–gp130TMD/ICD with signalling-deficient gp130 variants did not induce IL-6 signalling, suggesting that the assembly of hexameric complexes failed to dimerize the IL-6R-associated JAKs correctly. By mimicking the premature trimeric receptor complex, IL-6-mediated dimerization of IL-6RECD-gp130TMD/ICD with the single-cytokine-binding variant gp130ΔD1 induced signalling. Of note, IL-6 signalling via these synthetic gp130ΔD1:IL-6RECD-gp130TMD/ICD complexes resulted predominantly in STAT3 phosphorylation. A STAT3-dominated profile was also observed after IL-6-induced signalling mediated by a JAK-deficient IL–6RECD–gp130TMD/ICDΔJAK variant in complex with the JAK-proficient but STAT/ERK/AKT-deficient gp130JAKΔICD variant. Our data showed that effective ERK/AKT signalling could not be executed after intracellular domain swapping from gp130 to the IL-6R. Taken together, the chimeric IL-6R/gp130 receptor may be helpful in the creation of customized synthetic IL-6 signalling.
具有 STAT3 磷酸化主导激活特征的合成三聚体白细胞介素-6 受体复合物。
在白细胞介素(IL)-6 信号传导过程中,IL-6 位点 I 首先与 IL-6 受体(IL-6R)结合,然后 IL-6 位点 II 与 gp130 的 2/3 结构域相互作用,形成不成熟的三聚体 IL-6:IL-6R:gp130 受体复合物。然后,IL-6 位点 III 与对立的 gp130 的结构域 1 相互作用,促进成熟的六聚体受体复合物的形成。当两个 gp130 相关的 Janus 激酶(JAKs)的时空配对正确时,它们会发生反式磷酸化,从而以平衡的方式激活 STAT、ERK 和 AKT 通路。由于 STAT/ERK/AKT 磷酸化不需要 IL-6R 的胞内结构域(ICD),我们研究了嵌合的 IL-6RECD-gp130TMD/ICD 受体蛋白赋予生物活性的条件。对于 IL-6RECD-gp130TMD/ICD,IL-6R 的胞外结构域(ECD)与 gp130 的跨膜结构域(TMD)和 ICD 融合。IL-6RECD-gp130TMD/ICD与信号缺陷gp130变体共表达并不能诱导IL-6信号,这表明六聚体复合物的组装未能使与IL-6R相关的JAK正确二聚化。通过模拟过早出现的三聚体受体复合物,IL-6介导的IL-6RECD-gp130TMD/ICD与单细胞因子结合变体gp130ΔD1的二聚化诱导了信号传导。值得注意的是,通过这些合成的 gp130ΔD1:IL-6RECD-gp130TMD/ICD 复合物发出的 IL-6 信号主要导致 STAT3 磷酸化。在JAK缺陷的IL-6RECD-gp130TMD/ICDΔJAK变体与JAK缺陷但STAT/ERK/AKT缺陷的gp130JAKΔICD变体复合介导的IL-6诱导信号后,也观察到STAT3为主的情况。我们的数据显示,细胞内结构域从 gp130 换成 IL-6R 后,ERK/AKT 信号无法有效执行。综上所述,嵌合的 IL-6R/gp130 受体可能有助于创建定制的合成 IL-6 信号。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cytokine
Cytokine 医学-免疫学
CiteScore
7.60
自引率
2.60%
发文量
262
审稿时长
48 days
期刊介绍: The journal Cytokine has an open access mirror journal Cytokine: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. * Devoted exclusively to the study of the molecular biology, genetics, biochemistry, immunology, genome-wide association studies, pathobiology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, new cytokines, and chemokines, Cytokine provides comprehensive coverage of cytokines and their mechanisms of actions, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors. We will publish 3 major types of manuscripts: 1) Original manuscripts describing research results. 2) Basic and clinical reviews describing cytokine actions and regulation. 3) Short commentaries/perspectives on recently published aspects of cytokines, pathogenesis and clinical results.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信